| Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death MA Toscano, GA Bianco, JM Ilarregui, DO Croci, J Correale, ... Nature immunology 8 (8), 825-834, 2007 | 800 | 2007 |
| Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors DO Croci, JP Cerliani, T Dalotto-Moreno, SP Méndez-Huergo, ... Cell 156 (4), 744-758, 2014 | 544 | 2014 |
| Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 JM Ilarregui, DO Croci, GA Bianco, MA Toscano, M Salatino, ... Nature immunology 10 (9), 981-991, 2009 | 531 | 2009 |
| Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration SC Starossom, ID Mascanfroni, J Imitola, L Cao, K Raddassi, ... Immunity 37 (2), 249-263, 2012 | 383 | 2012 |
| Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer GA Rabinovich, DO Croci Immunity 36 (3), 322-335, 2012 | 367 | 2012 |
| Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease T Dalotto-Moreno, DO Croci, JP Cerliani, VC Martinez-Allo, ... Cancer research 73 (3), 1107-1117, 2013 | 308 | 2013 |
| Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment DO Croci, MF Zacarías Fluck, MJ Rico, P Matar, GA Rabinovich, ... Cancer immunology, immunotherapy 56, 1687-1700, 2007 | 286 | 2007 |
| Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma DO Croci, M Salatino, N Rubinstein, JP Cerliani, LE Cavallin, HJ Leung, ... Journal of Experimental Medicine 209 (11), 1985-2000, 2012 | 207 | 2012 |
| A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease DJ Laderach, LD Gentilini, L Giribaldi, VC Delgado, L Nugnes, DO Croci, ... Cancer research 73 (1), 86-96, 2013 | 194 | 2013 |
| Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem‐repeat” lectin galectin‐8 VMC Delgado, LG Nugnes, LL Colombo, MF Troncoso, MM Fernández, ... The FASEB Journal 25 (1), 242-254, 2011 | 173 | 2011 |
| Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function LA Pasquini, V Millet, HC Hoyos, JP Giannoni, DO Croci, M Marder, ... Cell Death & Differentiation 18 (11), 1746-1756, 2011 | 164 | 2011 |
| Fucans, but Not Fucomannoglucuronans, Determine the Biological Activities of Sulfated Polysaccharides from Laminaria saccharina Brown Seaweed DO Croci, A Cumashi, NA Ushakova, ME Preobrazhenskaya, A Piccoli, ... PLoS One 6 (2), e17283, 2011 | 142 | 2011 |
| Translating the ‘sugar code’into immune and vascular signaling programs JP Cerliani, AG Blidner, MA Toscano, DO Croci, GA Rabinovich Trends in biochemical sciences 42 (4), 255-273, 2017 | 116 | 2017 |
| Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer M Salatino, DO Croci, GA Bianco, JM Ilarregui, MA Toscano, ... Expert opinion on biological therapy 8 (1), 45-57, 2008 | 103 | 2008 |
| The immunoregulatory glycan‐binding protein galectin‐1 triggers human platelet activation N Pacienza, RG Pozner, GA Bianco, LP D'Atri, DO Croci, S Negrotto, ... The FASEB Journal 22 (4), 1113-1123, 2008 | 102 | 2008 |
| Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity? MA Toscano, JM Ilarregui, GA Bianco, L Campagna, DO Croci, M Salatino, ... Cytokine & growth factor reviews 18 (1-2), 57-71, 2007 | 101 | 2007 |
| Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues V Sundblad, DO Croci Russo, GA Rabinovich F Hernandez, 2011 | 92 | 2011 |
| Targeting galectin-driven regulatory circuits in cancer and fibrosis KV Mariño, AJ Cagnoni, DO Croci, GA Rabinovich Nature Reviews Drug Discovery 22 (4), 295-316, 2023 | 86 | 2023 |
| Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression LE Rossi, DE Avila, RG Spallanzani, A Ziblat, MB Fuertes, L Lapyckyj, ... Journal of leukocyte biology 91 (2), 321-331, 2012 | 83 | 2012 |
| Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells AJ Cagnoni, ML Giribaldi, AG Blidner, AM Cutine, SG Gatto, RM Morales, ... Proceedings of the National Academy of Sciences 118 (21), e2102950118, 2021 | 80 | 2021 |
Gabriel RabinovichInstituto de Biología y Medicina Experimental, CONICET and University of Buenos Aires, ArgentinaVerified email at ibyme.conicet.gov.ar
